PosterREPRINT CHARACTERISATION OF THE STAPHYLOCOCCUS SCIURI GROUP BY MATRIX-ASSISTED LASER DESORPTION/IONISATION TIME-OF-FLIGHT MASS SPECTROMETRY

Similar documents
Methicillin-Resistant Staphylococcus aureus

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

Antimicrobial Resistance

CHAPTER 1 INTRODUCTION

Brief Report THE DEVELOPMENT OF VANCOMYCIN RESISTANCE IN A PATIENT WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION

National MRSA Reference Laboratory

Int.J.Curr.Microbiol.App.Sci (2018) 7(8):

Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana

Geoffrey Coombs 1, Graeme Nimmo 2, Julie Pearson 1, Samantha Cramer 1 and Keryn Christiansen 1

Detection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a tertiary care hospital

Bacterial whole genome sequencing in clinical microbiology, infection control and public health. Julian Parkhill. FIS, Birmingham, November 2013

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Burn Infection & Laboratory Diagnosis

Why Don t These Drugs Work Anymore? Biosciences in the 21 st Century Dr. Amber Rice October 28, 2013

First there was Staphylococcus intermedius.

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

WHY IS THIS IMPORTANT?

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Tel: Fax:

Impact of Antimicrobial Resistance on Human Health. Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

MRSA surveillance 2014: Poultry

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families

SCOTTISH MRSA REFERENCE LABORATORY

Urban Water Security Research Alliance

Antibiotic resistance: how did we get here and what can we do? Peter Lambert LHS

A Study on Bacterial Flora on the Finger printing Surface of the Biometric Devices at a Tertiary Care Hospital

NASAL COLONIZATION WITH STAPHYLOCOCCUS AUREUS IN BASRA MEDICAL AND DENTISTRY STUDENTS

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Int.J.Curr.Microbiol.App.Sci (2014) 3(1): 23-29

Detection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital

Source: Portland State University Population Research Center (

Acinetobacter species-associated infections and their antibiotic susceptibility profiles in Malaysia.

An Approach to Linezolid and Vancomycin against Methicillin Resistant Staphylococcus Aureus

Service Delivery and Safety Department World Health Organization, Headquarters

Methicillin-resistant coagulase-negative staphylococci Methicillin-resistant. spa Staphylococcus aureus

HardyCHROM MRSA, Contact Plate

Rise of the Superbugs: the end of antibiotics? Peter Lambert Life and Health Sciences Aston University

Anaerobe bakterier og resistens. Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark

Rapid molecular testing to detect Staphylococcus aureus in positive blood cultures improves patient management. Martin McHugh Clinical Scientist

Mechanisms and Pathways of AMR in the environment

Ca-MRSA Update- Hand Infections. Washington Hand Society September 19, 2007

MRSA Control : Belgian policy

Multi-drug resistant microorganisms

Staphylococcus pseudintermedius: Population Genetics and Antimicrobial Resistance

Staphylococcus aureus nasal carriage in diabetic patients in a tertiary care hospital

Randall Singer, DVM, MPVM, PhD

SCOTTISH MRSA REFERENCE LABORATORY

Typhoid fever - priorities for research and development of new treatments

DRUG-RESISTANT ACINETOBACTER BAUMANNII A GROWING SUPERBUG POPULATION. Cara Wilder Ph.D. Technical Writer March 13 th 2014

NUOVE IPOTESI e MODELLI di STEWARDSHIP

Failure of Cloxacillin in a Patient with BORSA Endocarditis ACCEPTED

Frequency of MecA, Van A and Van B Genes in Staphylococcus aureus isolates among pediatric clinical specimens in Khartoum Hospitals 2017

MRCoNS : .Duplex-PCR.

Antimicrobial Resistance and Papua New Guinea WHY is it important? HOW has the problem arisen? WHAT can we do?

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance

A Unique Approach to Managing the Problem of Antibiotic Resistance

Overview of Infection Control and Prevention

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

Volume-7, Issue-2, April-June-2016 Coden IJABFP-CAS-USA Received: 5 th Mar 2016 Revised: 11 th April 2016 Accepted: 13 th April 2016 Research article

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

FM - Male, 38YO. MRSA nasal swab (+) Due to positive MRSA nasal swab test, patient will be continued on Vancomycin 1500mg IV q12 for MRSA treatment...

Antimicrobial stewardship: Quick, don t just do something! Stand there!

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Int.J.Curr.Microbiol.App.Sci (2016) 5(12):

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

ABSTRACT. The Distribution and Resistance to Antibiotics of Staphylococcus Organisms Among the Equine Population of Central Texas

Antimicrobial Resistance and Prescribing

Association between teat skin colonization and intramammary infections with Staphylococcus aureus and Streptococcus agalactiae

What do we know about multidrug resistant bacteria in New Zealand s pet animals?

Presence of extended spectrum β-lactamase producing Escherichia coli in

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Global Status of Antimicrobial Resistance with a Focus on Nepal

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran

Int.J.Curr.Microbiol.App.Sci (2015) 4(9):

Dynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus

The Search For Antibiotics BY: ASLEY, ELIANA, ISABELLA AND LUNISCHA BSC1005 LAB 4/18/2018

Why we perform susceptibility testing

Finnzymes Oy. PathoProof Mastitis PCR Assay. Real time PCR based mastitis testing in milk monitoring programs

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Today s Agenda: 9/30/14

Occurrence of Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Srinagarind Hospital

BIOLACTAM. Product Description. An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity

Methicillin resistant Staphylococcus aureus (MRSA) Lina Cavaco

Determination of antibiotic sensitivities by the

CONFLICT OF INTEREST ANTIMICROBIAL LOCK SOLUTIONS INCREASE BACTEREMIA

WILDLIFE HEALTH AUSTRALIA SUBMISSION: STAKEHOLDER CONSULTATION - DEVELOPING A NATIONAL ANTIMICROBIAL RESISTANCE STRATEGY FOR AUSTRALIA

Name(s): Period: Date:

ANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh

Multi-Drug Resistant Organisms (MDRO)

Evolution of antibiotic resistance. October 10, 2005

Impact of a Standardized Protocol to Address Outbreak of Methicillin-resistant

Comparison of Antibiotic Resistance and Sensitivity with Reference to Ages of Elders

CME/SAM. Validation and Implementation of the GeneXpert MRSA/SA Blood Culture Assay in a Pediatric Setting

Transcription:

Abstract Staphylococcus aureus and coagulase-negative staphylococci (CNS) are recognised as important nosocomial pathogens. Laboratory identification and susceptibility testing remain important tools in the epidemiology and control of staphylococcal infection. Multi-drug resistance, particularly methicillin resistance is an escalating problem. The mechanism of resistance among S.aureus (MRSA) and CNS is encoded by the meca gene, and has been found to be ubiquitous among the primitive animal CNS - Staphylococcus sciuri. It has been hypothesised that S.sciuri is a natural reservoir of methicillin resistance genes. Until recently S.sciuri has seldom been recovered from clinical material and rarely implicated in human infections. Over the past three years at Ashford Public Health Laboratory, 160 isolates of S.sciuri identified using the API32 Staph (Biomerieux) have been recovered from clinical samples, 30% of which expressed methicillin resistance. Seventeen ATCC strains of the S.sciuri group, comprising of S.sciuri subsp. sciuri, S.sciuri subsp. carnaticus, S.sciuri subsp. rodentium, S.lentus and S.vitulinus were analysed using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF-MS) and a database created. The aim of this study is to identify and compare clinical and non-clinical isolates using MALDI-TOF-MS. The results will be used to assess any correlation between subspecies of S.sciuri, and whether there is a link between expressed methicillin resistance in clinical isolates and assumed exposure to antibiotic pressure by comparing hospital acquired isolates with the community acquired isolates. CHARACTERISATION OF THE STAPHYLOCOCCUS SCIURI GROUP BY MATRIX-ASSISTED LASER DESORPTION/IONISATION TIME-OF-FLIGHT MASS SPECTROMETRY M. C. Coales, Ashford Public Health Laboratory, Ashford, UK A. W. Bunch, University of Kent at Canterbury, Canterbury, UK T. McKenna & J. Batchelor, Waters Corporation, Manchester, UK Presented at ASM 2002, Salt Lake City, Utah, USA, 19 th -23 rd May, 2002 Introduction Staphylococcus sciuri is a coagulase-negative novobiocin resistant staphylococcus primarily of animal origin, first described by Kloos et al in 1976. Over the last two decades this staphylococcus has seldom been recovered from humans and and other primates (Hajek V and Balusek J, 1985). It has been suggested that S.sciuri isolates recovered from humans may be a consequence of them having pets or recent contact with farm animals (Kloos WE, Schleifer, RF Smith RF, 1976). However, in recent years there has been a greater incidence reported in clinical material, such as boils (Adegoke GO, 1986), wound infections (Udo EE et al, 1995, Kalowole DO, Shittu AO, 1997, Marsou et al, 1999, Aires De Sousa et al 2000), blood cultures (Udo EE et al, 1995, Marsou et al, 1999), CAPD-associated peritonitis (Marsou et al, 1999, Lang S et al, 1999, Wallet F et al, 2001), intravenous catheters (Horii T et al, 2001) and endocarditis (Hendin G and Widerstrom M, 1998). The most significant aspect about this organism is the presence of a meca gene, which in S. aureus and coagulase-negative staphylococci encodes for methicillin resistance (Chambers HF, 1997) which is a major nosocomial problem on a global scale. The meca gene is found uniformly distributed among S.sciuri (Couto et al, 1996, Wu et al, 1996, Wu et al, 1998). However, the meca gene along with the transcriptional repressor gene meci found in the chromosomal DNA of this organism may not have initially been involved in antibiotic resistance, but instead encoding for a protein as a normal function of cell wall biosynthesis (Couto et al, 1996, Wu et al, 1996).

Expressed methicillin resistance among strains of S.sciuri subsp. rodentium has been observed in recent years. These isolates were shown to have more than one copy of the meca gene i.e. a meca gene similar to that of an MRSA called "MRSA meca" and another called "sciuri meca". In contrast strains of S.sciuri subsp. carnaticus and S.sciuri subsp. sciuri were susceptible to methicillin and carried only a single copy of the meca gene - "sciuri meca" (Couto et al, 1996, Wu et al, 1996, Couto et al, 2000). These strains of S.sciuri subsp. rodentium were recovered from humans and animals that had been exposed to an antibiotic-rich environment. Resistance to methicillin seen in these strains of S.sciuri may have evolved due to point mutations in the meca sequence reducing the affinity of an active site for methicillin, which may have been driven by increased antibiotic pressures (Couto et al, 1996). In a recent study carried out by the same workers, strains of S.sciuri that possess the MRSA meca gene, were recovered from humans that had not been exposed to an antibiotic rich environment thus indicating there is no correlation between carriage of S.sciuri with the MRSA meca gene and antibiotic consumption (Couto et al, 2000). Recent experimental evidence has shown that the meca gene of S.sciuri, which has an as yet undefined domestic function, can be recruited to become a resistance determinant under conditions of antibiotic selection. The actual process that makes the silent "sciuri meca" homologue of the methicillin susceptible S.sciuri strain become methicillin resistant determinant appears to be the replacement of a single nucleotide within the promoter sequence. This results in an increase in the rate of transcription of the gene into a penicillin binding like-protein, that closely resembles PBP2A of the S.aureus meca determinant (Wu et al, 2001). All methicillin-resistant strains of S.aureus are clonal descendants from a few ancestral strains that acquired the meca gene. The meca containing DNA is not readily self-transmissible, but some horizontal transfer must have occurred to have reached coagulase-negative staphylococci as well as S.aureus (Hiramatsu K et al, 1999). Recent evidence suggests that in-vivo horizontal transfer of meca DNA from a meca + S.epidermidis to a meca- S.aureus did occur in a patient during treatment with flucloxacillin (Weilders CLC, et al 2001). This supports the hypothesis that S.sciuri may serve as a reservoir of the meca gene and may have been the evolutionary precursor of the structural gene PBP2a and the mechanism of methicillin resistance seen in S.aureus and coagulase-negative staphylococci (Couto et al, 1996). An attempt was made to investigate whether expressed methicillin resistance is confined to a particular sub species of S.sciuri and subsequently a source of meca by comparison of community and hospital acquired isolates. Conventional biochemical identification systems such as API (Biomeriuex), although able to confirm their identity, did not offer further speciation of the S.sciuri group. Molecular methods such as 16S rrna and 16S-23S rdna ITS-PCR although well established taxonomic tools, do require some degree of expertise and can be time consuming. Speciation of the S.sciuri group was achieved by performing matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI TOF MS). MALDI TOF MS is a rapid method of analyzing the cell surface components of microorganisms. It is these surface components which generate ions which produce a reproducible mass spectrum or fingerprint within a few minutes and is species, and in some case strain specific (Claydon M A, et al 1996). MALDI TOF MS has recently enabled the rapid discrimination between methicillin-sensitive

and methicillin-resistant S.aureus (Edwards-Jones V, et al 2000) and would serve as a key epidemiological tool. It is highly likely that the distinguishing factor between these strains is the presence of a cell-surface moiety that is linked with the production of PBP2a. Method Bacterial cultures Sixteen strains of the S.sciuri group were selected for analysis by matrix-assisted laser desorption/ionisation time of flight mass spectrometry (MALDI TOF MS). These comprised: four strains of S.sciuri subsp. sciuri (ATCC 29059, ATCC 29061, ATCC 29062 T, DM93), three strains of S.sciuri subsp. carnaticus (ATCC 700058T, ATCC 700059, ATCC 700060), three strains S.sciuri subsp. rodentiium (ATCC 700061T, ATCC 700062, ATCC 700063), three strains of of S.lentus (ATCC 29070T, K-2, K-15) and three strains of S.vitulinus (ATCC 51145 T, ATCC 51162, ATCC 51163). The above were obtained from the North Carolina State University, Raleigh, North Carolina, USA. and are used to build a database. In addition a number of clinical isolates were analysed and compared to this database. All isolates were stored at -80 C using Cryobeads (Prolab diagnostics) and were sub-cultured on Columbia blood agar (CPHL), incubated at 37 C overnight prior to analysis. Preparation of the bacteria for analysis by MALDI- TOF MS Using a sterile disposable plastic 1uL loop a sweep of pure colonies was taken and applied to the wells of the target plate, to give a uniform surface coating. 12 replicates were used for each strain. Each sample well was overlain with 1uL of a freshly prepared matrix solution, 5-chloro-2- mercaptobenzothiazole (CMBT) at 3.0 mg/ml used for Gram positive organisms. The matrix was dissolved in acetonitrile:methanol:water (1:1:1) with 0.1% formic acid and 0.01M 18-crown-6 ether. A seven peptide mixture of known molecular weight standards, was pipetted onto the lock mass wells of the target plate. These peptides included bradykinin 1pmol/uL, angiotensin 1 1pmol/uL, Glu-fibrinopeptide B 1pmol/uL, renin substrate tetra deca peptide 1pmol/uL, ACTH (18-39 clip) 1pmol/uL, bovine insulin 2pmol/uL and ubiquitin 10pmol/uL. The target plate was then allowed to dry in air. MALDI-TOF MS analysis was carried out using the M@LDI Linear time-of-flight mass spectrometer (Waters Corporation). A nitrogen laser giving a 337nm output of 3ns-pulse width was used and the laser fluence was set just above the threshold for ion production. The mass spectrometer was used in the positive ion detection mode using an acceleration voltage of +15kV. The data acquisition mass range was from m/z 500 to 10000 Da. The lock mass calibration was determined from the renin substrate ion at 1760 Da. For maximum throughput of samples the bacterial mass fingerprints were acquired automatically using the MAXspec real-time data selection algorithm to optimise the bacterial fingerprint signal in the mass range 600 to 3000 Da. MicrobeLynx data analysis For each strain, twelve replicates were compared for reproducibility using the root mean square (RMS) value. This value is obtained by comparing each replicate in turn with the average of the other 11 replicates, as shown in Figure 1a and 1b. An RMS rejection value of 3 was used to identify outliers significant at the 0.1% level. The acceptable spectra were then combined to give a representative spectral pattern for each organism, Figure 2, from which a database was prepared. Dendrograms were produced by an algorithm, where the proximity of one organism to another was generated using a spectral RMS calculation. Each node of the dendrogram is singly linked and organisms are grouped together using a simple average proximity.

Figure 1a. MicrobeLynx Browser showing reproducibility of replicate spectra Results A database was generated from the organisms listed in Table 1. Genus species Sub species strain Staphylococcus sciuri sciuri ATCC 29059 Staphylococcus sciuri sciuri ATCC 29061 Staphylococcus sciuri sciuri ATCC 29062 T Staphylococcus sciuri sciuri DM93 Staphylococcus sciuri carnaticus ATCC 700058 T Staphylococcus sciuri carnaticus ATCC 700059 Staphylococcus sciuri carnaticus ATCC 700060 Staphylococcus sciuri rodentium ATCC 700061 T Staphylococcus sciuri rodentium ATCC 700062 Staphylococcus sciuri rodentium ATCC 700063 Staphylococcus lentus ATCC 29070 T Staphylococcus lentus K-2 Staphylococcus lentus K-15 Staphylococcus vitulinus ATCC 51145 T Staphylococcus vitulinus ATCC 51162 Staphylococcus vitulinus ATCC 51163 Table 1. Figure 1b. Comparison of the RMS values for 12 replicate spectra from Staphylococcus scuiri sub species carnaticus ATCC 700060 These averaged spectra in the database were clustered together and displayed as a dendrogram. The dendrogram, Figure 3, shows the relationship between the different species and sub species of Staphylococcus scuiri group and infers the level of discrimination possible using MALDI TOF MS. These strains fall into four main groups with Staphylococcus lentus being the most distantly related strain. Staphylococcus vitulinus and Staphylococcus scuiri sub species scuiri are clearly separated from each other and from the other more closely related Staphylococcus scuiri sub species carnaticus and Staphylococcus scuiri sub species rodentium. Figure 2. Average mass spectrum from database entry for Staphylococcus scuiri sub species carnaticus ATCC 700060

Created from database: T:\Coales.PRO\Scuiri.bdb Staphylococcus lentus ATCC 29070(T) Staphylococcus lentus K15 Staphylococcus lentus K-2 Staphylococcus sciuri carnaticus ATCC 700058(T) Staphylococcus sciuri carnaticus ATCC 700059 Staphylococcus sciuri carnaticus ATCC 700060 Staphylococcus sciuri rodentium ATCC 700061(T) Staphylococcus sciuri rodentium ATCC 700062 Staphylococcus sciuri rodentium ATCC 700063 Staphylococcus sciuri sciuri DM93 Staphylococcus sciuri sciuri ATCC 29062 Staphylococcus sciuri sciuri ATCC 29059 Figure 4. Results Browser for 8 clinical isolates showing the 2 best matches in the database Staphylococcus sciuri scuiri ATCC 29061 Staphylococcus vitulinus ATCC 51145(T) Staphylococcus vitulinus ATCC 51163 Staphylococcus vitulinus ATCC 51162 0.0 0.25 0.5 0.75 1.0 Rel. Diff. Figure 3. Dendrogram of the mass spectral fingerprints generated by MALDI TOF MS of the 16 strains of the Staphylococcus scuiri group An initial study of 8 clinical isolates, which had previously been biochemically typed as Staphylococcus scuiri group only, was undertaken. Each of these isolates were searched against this Scuiri type-strain database and against a commercial database of ~700 entries generated by Manchester Metropolitan University, UK in collaboration with the NCTC, CPHL, London UK. These eight clinical strains were clustered along with the scuiri database indicating their relationships to the database entries. This dendrogram is shown in Figure 5 and shows the SS1 isolate clusters close to the Staphylococcus scuiri sub species rodentium, SS3 close to Staphylococcus scuiri sub species carnaticus and the other six isolates in the Staphylococcus scuiri sub species scuiri group. Created from database: T:\Coales.PRO\alldatasciuir.bdb Staphylococcus vitulinus ATCC 51145(T) Staphylococcus vitulinus ATCC 51162 Staphylococcus vitulinus ATCC 51163 Staphylococcus sciuri rodentium ATCC 700063 Staphylococcus sciuri sciuri ATCC 29062 Staphylococcus sciuri carnaticus ATCC 700058(T) Staphylococcus sciuri rodentium ATCC 700062 Staphylococcus sciuri rodentium ATCC 700061(T) Staphylococcus sciuri ss1 Staphylococcus sciuri carnaticus ATCC 700059 Staphylococcus sciuri ss3 The MicrobeLynx results browser for these 8 clinical isolates is shown in Figure 4. The result for isolate SS1 highlighted and shows that the top eight hits are all Staphylococcus scuiri. More specifically there is a 97% probability that the best match is a Staphylococcus scuiri sub species rodentium. Staphylococcus sciuri carnaticus ATCC 700060 Staphylococcus sciuri scuiri ATCC 29059 Staphylococcus sciuri ATCC 29061 Staphylococcus sciuri ss5 Staphylococcus sciuri ss2 Staphylococcus sciuri sciuri Staphylococcus sciuri ss7 Staphylococcus sciuri ss6 Staphylococcus sciuri ss9 Staphylococcus sciuri ss8 Staphylococcus lentus ATCC 29070(T) Staphylococcus lentus K-15 Staphylococcus lentus K-2 0.0 0.25 0.5 0.75 1.0 Rel. Diff. Figure 5. Dendrogram of the mass spectral fingerprints generated by MALDI TOF MS of the 16 strains of the Staphylococcus scuiri group clustered with 8 clinical isolates

Conclusion A database was generated from sixteen different species and sub species of Staphylococcus scuiri group The relationship between the group members could be inferred by the generation of a dendrogram, produced by comparison of their mass spectral fingerprints. Four main groups could be discriminated using MALDI TOF MS with Staphylococcus lentus being the most distantly related strain. Staphylococcus vitulinus and Staphylococcus scuiri sub species scuiri are clearly separated from each other and from the other more closely related Staphylococcus scuiri sub species carnaticus and Staphylococcus scuiri sub species rodentium. The 8 clinical isolates were all identified as Staphylococcus scuiri. Further work is required to determine the level of discrimination possible by MALDI TOF MS References 1. Adegoke, G. O. 1986. Comparative characteristics of Staphylococcus sciuri, Staphylococcus lentus and Staphylococcus gallinarum isolated from healthy and sick hosts. Vet. Microbiol. 11: 185-189. 4. Couto, I., I. Santos Sanches, R. Sa-Leao, and H. de Lencastre. 2000. Molecular characterisation of Staphylococcus sciuri isolates isolated from humans. J. Clin. Microbiol. 38:1136-1143. 5. Chambers, H. F. 1997. Methicillin Resistance in Staphylococci: Molecular and Biochemical Basis and Clinical Implications. Clin. Micribiol. Rev. 10:781-791. 6. Claydon, M. A., S. N. Davey, V. Edwards-Jones, D. B. Gordon. 1996. The rapid identification of microorganisms using mass spectrometry. Nature Biotech. 14:1584-1586. 7. Edwards-Jones, V., M. A. Claydon, D. J. Evason, J. Walker, A. J. Fox and D. B. Gordon. 2000. Rapid discrimination between methicillinsensitive and methicillin-resistant Staphylococcus aureus by intact cell mass spectrometry. J. Med. Microbiol. 49: 295-30. 8. Hajek, V., and J. Baleusek. 1985. Staphylococci from flies of different environments, p.129-133. In J. Jeljazewics (ed.), The Staphylococci. Gustav Fischer Verlag, Stuttgart, Germany. 9. Hendin, G., and M. Widerstrom. 1998. Endocarditis due to Staphylococcus sciuri. Eur. J. Clin. Micro. 17:673-674. 10.Hiramatsu, K., K. Ito, and H. Hanaki. 1999. Mechansims of methicillin and vancomycin resistance in Staphylococcus aureus. J. Bacteriol. 158: 513-516. 2. Aires De Sousa, M., I. Santos Sanches, M. L. Ferro, and H. De Lencestre. 2000. Epidemiological study of Staphylococcal Colonistaion and Cross-Infection in Two West African Hospitals. Microbial. Drug. Res. 6:133-141. 3. Couto, I., H. de Lencastre, E. Severina, W. E. Kloos, J. A. Webster, R. J. Hubner, I. Santos Sanches, and A. Tomasz. 1996. Ubiquitous presence of a meca homologue in natural isolates of Staphylococcus sciuri. Microb Drug Resist. 2:377-391. 11.Horii, T., Y. Susuki, T. Kimura, T. Kanno, and M. Macawa. 2001. Intravenous catheter-related septic shock caused by Staphylococcus sciuri and Eschericia vulneris. Scand. J. Infect. Dis. 33(12): 930-932. 12.Kalowole, D. O, and A. O. Shittu. 1997. Unusual recovery of animal staphylococci from septic wounds of hospital patients in Ile-Ife, Nigeria. Lett. Appl. Microbiol. 24:87-50.

13.Kloos, W. E., K. H. Schleifer, and R. F. Smith.1976. Characterization of Staphylococcus sciuri sp. nov. and its subspecies. Int. J. Syst. Bacteriol. 26: 22-37. 14.Lang, S., M. A. Livesley, P. A. Lambert, J. Elliot, and T. S. J. Elliot. 1999. The genomic diversity of coagulase-negative staphylococci associated with nosocomial infections. J. Hosp. Infect. 43:187-193. 15.Marsou, R., M. Bes, M. Boudouma, Y. Brun, H. Meughnier, J. Freney, F. Vandensch, and J. Etienne.1999. Distribution of Staphylococcus sciuri subspecies among human clinical specimens, and profile of antibiotic resistance. Res. Microbiol. 150:531-541. 20.Wu, S., de Lencastre H and Tomasz A. 2001.Recruitment of the meca Gene Homologue of Staphylococcus sciuri into a Resistance Determinant and Expression of the Resistant Phenotype in Staphylococcus aureus. J. Bacteriol. 183(8): 2417-2424. 16.Wallet, F., L. Stuit, M. Roussel-Delvallez, P. Dequiedt, R. J. C. 2001. Peritonitis due to Staphylococcus sciuri in a patient on continuous ambulatory peritoneal dialysis. Scand. J. Infect. Dis. 32(6):697-698. 17.Wielders, C. L. C., M. R. Vriens, S. Brisse, L. A. M. de Graf-Miltenburg, A. Troelstra, A. Fleer, F. J. Scmitz, J. Verhoef, and A. C. Fluit. 2001. Evidence for in-vivo transfer of meca DNA between isolates of Staphylococcus aureus. Lancet. 357: 1674-1675. 18.Wu, S., Piscitelli, H. de Lencastre, and A. Tomasz. 1996. Tracking the Evolutionary Origin of the Methicillin Resistance Gene: Cloning and Sequencing of a Homologue of meca from a methicillin Susceptible Isolate of Staphylococcus sciuri. Microbial. Drug. Res. 2: 435-441. 19.Wu, S., de Lencastre H and Tomasz A.1998. Genetic Organization of the meca Region in Methicillin susceptible and Methicillin-Resistant Isolates of Staphylococcus sciuri. J. bacteriol. 180: 236-242.

Author to whom all correspondence should be addressed: Thérèse McKenna Waters Corporation (Micromass UK Limited) Floats Road, Wythenshawe Manchester, M23 9LZ Tel: + 44 (0) 161 946 2400 Fax: + 44 (0) 161 946 2480 e-mail: therese.mckenna@micromass.co.uk WATERS CORPORATION 34 Maple St. Milford, MA 01757 U.S.A. T: 508 478 2000 F: 508 872 1990 www.waters.com Made in the United Kingdom 2002 Waters Corporation November 2002 / WMP232 For research use only. Not for use in diagnostic procedures. Certificate No: 951387